Human Pathology
Volume 41, Issue 5 , Pages 672-678 , May 2010

Fibrocytes are involved in the pathogenesis of human chronic kidney disease

  • Norihiko Sakai, MD, PhD

      Affiliations

    • Division of Blood Purification, Kanazawa University Hospital, Kanazawa 920-8641, Japan
    • ,
  • Kengo Furuichi, MD, PhD

      Affiliations

    • Division of Blood Purification, Kanazawa University Hospital, Kanazawa 920-8641, Japan
    • ,
  • Yasuyuki Shinozaki, MD

      Affiliations

    • Faculty of Medicine, Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • ,
  • Hiroyuki Yamauchi, MD

      Affiliations

    • Faculty of Medicine, Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • ,
  • Tadashi Toyama, MD

      Affiliations

    • Faculty of Medicine, Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • ,
  • Shinji Kitajima, MD

      Affiliations

    • Faculty of Medicine, Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • ,
  • Toshiya Okumura, MD

      Affiliations

    • Faculty of Medicine, Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • ,
  • Satoshi Kokubo, MD

      Affiliations

    • Faculty of Medicine, Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • ,
  • Motoo Kobayashi, MD

      Affiliations

    • Faculty of Medicine, Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • ,
  • Kazuya Takasawa, MD, PhD

      Affiliations

    • Department of Internal Medicine, Public Central Hospital of Matto Ishikawa, Hakusan 924-8588, Japan
    • ,
  • Shin-ichi Takeda, MD, PhD

      Affiliations

    • Department of Internal Medicine, Kurobe Municipal Hospital, Kurobe 933-8502, Japan
    • ,
  • Mitsuhiro Yoshimura, MD, PhD

      Affiliations

    • Department of Internal Medicine, Kanazawa Medical Center, Kanazawa 920-8650, Japan
    • ,
  • Shuichi Kaneko, MD, PhD

      Affiliations

    • Faculty of Medicine, Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • ,
  • Takashi Wada, MD, PhD

      Affiliations

    • Faculty of Medicine, Department of Laboratory Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan
    • Corresponding Author InformationCorresponding author.

Received 5 August 2009 ,Revised 30 September 2009 ,Accepted 8 October 2009.

References 

  1. Stenvinkel P, Carrero JJ, Axelsson J, et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. Clin J Am Soc Nephrol. 2008;3:505–521
  2. Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int. 1998;54:992–994
  3. Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003;9:964–968
  4. Kitagawa K, Wada T, Furuichi K, et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol. 2004;165:237–246
  5. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114:438–446
  6. Sakai N, Wada T, Yokoyama H, et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A. 2006;103:14098–14103
  7. Kisseleva T, Uchinami H, Feirt N, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol. 2006;45:429–438
  8. Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001;166:7556–7562
  9. Wada T, Sakai N. Matsushima, et al. Fibrocytes: a new insight into kidney fibrosis. Kidney Int. 2007;72:269–273
  10. Chesney J, Metz C, Stavitsky AB, et al. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 1998;160:419–425
  11. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1:71–81
  12. Bucala R. Circulating fibrocytes: cellular basis for NSF. J Am Coll Radiol. 2008;5:36–39
  13. Schmidt M, Sun G, Stacey MA, et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol. 2003;171:380–389
  14. Yang L, Scott PG, Giuffre J, et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest. 2002;82:1183–1192
  15. Sakai N, Wada T, Matsushima K, et al. The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens. 2008;26:780–790
  16. Moore BB, Kolodsick JE, Thannickal VJ, et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol. 2005;166:675–684
  17. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
  18. Yokoyama H, Wada T, Hara A, et al. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int. 2004;66:2382–2388
  19. Iseki K, Horio M, Imai E, et al. Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa. Clin Exp Nephrol. 2009;13:44–49
  20. Sakai N, Wada T, Furuichi K, et al. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis. 2005;45:54–65
  21. Wada T, Furuichi K, Segawa-Takaeda C, et al. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int. 1999;56:995–1003
  22. Ishida Y, Kimura A, Takayasu T, et al. Detection of fibrocytes in human skin wounds and its application for wound age determination. Int J Legal Med. 2009;123:299–304
  23. Saunders R, Siddiqui S, Kaur D, et al. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J Allergy Clin Immunol. 2009;123:376–384
  24. Abu El-Asrar AM, Struyf S, Van Damme J, et al. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol. 2008;92:699–704
  25. Hohenstein B, Daniel C, Hausknecht B, et al. Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy. Nephrol Dial Transplant. 2008;23:3880–3887
  26. Wada T, Furuichi K, Sakai N, et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol. 2004;15:940–948
  27. Wada T, Furuichi K, Sakai N, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int. 2000;58:1492–1499
  28. Sordi V. Mesenchymal stem cell homing capacity. Transplantation. 2009;87:S42–S45
  29. Wada T, Furuichi K, Sakai N, et al. Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis. 2001;38:1169–1177
  30. Iwata Y, Wada T, Furuichi K, et al. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice. J Am Soc Nephrol. 2003;14:57–67
  31. Lim AK, Nikolic-Paterson DJ, Ma FY, et al. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia. 2009;52:347–358
  32. Hong KM, Belperio JA, Keane MP, et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem. 2007;282:22910–22920
  33. Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759–766
  34. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869
  35. Moeller A, Gilpin SE, Ask K, et al. Circulating Fibrocytes Are an Indicator for Poor Prognosis in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2009;179:588–594

☆ This work was supported by a Grant-in-aid from the Ministry of Education, Science, Sport and Culture of Japan and Takeda Science Foundation (T.W.) and CKD AWARD 2008 from Nippon Boehringer Ingelheim Co, Ltd, and Astellas Pharma Inc (NS).

PII: S0046-8177(09)00373-6

doi: 10.1016/j.humpath.2009.10.008

Human Pathology
Volume 41, Issue 5 , Pages 672-678 , May 2010

Article Tools

* Image Usage & Resolution